Tedizolid

🧮 Dose calculator

Skin and skin structure infection · Regimen source: FDA Sivextro · 2.2, Table 1

• • Do not give tablets to children under 35 kg. IV-to-oral switch needs no adjustment. FDA Sivextro · 2FDA Sivextro · 2.2

Enter age and weight.

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Sivextro · 8.1

  “Risk Summary Based on animal reproduction studies, SIVEXTRO may cause fetal harm when administered to pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Sivextro · 8.2

  “Risk Summary There is no information on the presence of tedizolid in human milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Sivextro · 8.4

  “The safety and effectiveness of SIVEXTRO for the treatment of ABSSSI have been established in pediatric patients at least 26 weeks gestational age and weighing at least 1 kg.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Sivextro · 8.5

  “No overall differences in pharmacokinetics were observed between elderly subjects and younger subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.